MedPath

Adherence to Lumefantrine-Artemether

Completed
Conditions
Malaria, Uncomplicated
Registration Number
NCT00153491
Lead Sponsor
Centers for Disease Control and Prevention
Brief Summary

This is a study of how well caregivers of children with malaria adhere to the recommended regimen for lumefantrine-artemether (LA). Children were randomly assigned to either a group receiving directly observed treatment in hospital or to a group treated at home by the routine caregiver (typically, patient's mother). Clinical/parasitologic, hematologic, pharmacologic and qualitative parameters were monitored over a 28-day follow-up period and are used to evaluate drug adherence.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mkuranga District Hospital

🇹🇿

Mkuranga, Mkuranga District, Tanzania

© Copyright 2025. All Rights Reserved by MedPath